Exicure Inc (XCUR) - Total Liabilities

Latest as of December 2025: $10.12 Million USD

Based on the latest financial reports, Exicure Inc (XCUR) has total liabilities worth $10.12 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Exicure Inc cash flow conversion to assess how effectively this company generates cash.

Exicure Inc - Total Liabilities Trend (2015–2025)

This chart illustrates how Exicure Inc's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Exicure Inc's assets to evaluate the company's liquid asset resilience ratio.

Exicure Inc Competitors by Total Liabilities

The table below lists competitors of Exicure Inc ranked by their total liabilities.

Company Country Total Liabilities
Sala @ Sathorn Property Fund
BK:SSPF
Thailand ฿19.90 Million
Yonga Mobilya Sanayi ve Ticaret AS
IS:YONGA
Turkey TL36.37 Million
Haily Group Bhd
KLSE:0237
Malaysia RM145.51 Million
Cyngn Inc
NASDAQ:CYN
USA $11.30 Million
Ennogie Solar Group A/S
CO:ESG
Denmark Dkr50.31 Million
OB Holdings Berhad
KLSE:0327
Malaysia RM15.84 Million
Celsius Resources Ltd
AU:CLA
Australia AU$5.65 Million
STS Group AG
XETRA:SF3
Germany €177.70 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Exicure Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see XCUR stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.19 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.58 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.72 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Exicure Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Exicure Inc (2015–2025)

The table below shows the annual total liabilities of Exicure Inc from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $10.12 Million +22.10%
2024-12-31 $8.28 Million -3.10%
2023-12-31 $8.55 Million +1.70%
2022-12-31 $8.41 Million -84.33%
2021-12-31 $53.64 Million +37.75%
2020-12-31 $38.94 Million +12.81%
2019-12-31 $34.52 Million +342.29%
2018-12-31 $7.80 Million -13.40%
2017-12-31 $9.01 Million -50.29%
2016-12-31 $18.13 Million +1203.24%
2015-12-31 $1.39 Million --

About Exicure Inc

NASDAQ:XCUR USA Biotechnology
Market Cap
$20.65 Million
Market Cap Rank
#24934 Global
#5072 in USA
Share Price
$3.24
Change (1 day)
-3.57%
52-Week Range
$3.24 - $11.86
All Time High
$975.00
About

Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.